H1 2025 results - Continued improvement in results and financial position
On 6ix: 6ix.com/news/spineway-h1-2025-results-continued-improvement-in-results-and-financial-position
The original release is unavailable here.
Earlier from Spineway
- Spineway: GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses
- Minutes of the General Meeting of June 4, 2025
- Spineway: Combined General Meeting of June 4, 2025 - Availability of preparatory documents
Later from Spineway
- Revenue growth in the third quarter
- 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
- 2025 annual results
- Compte-rendu de l’Assemblée Générale du 2 avril 2026
- Minutes of the General Meeting of April 2, 2026
Follow Spineway into a list and get an email when it puts out news.
Follow Spineway